 Carroll Financial Associates Inc. purchased a new position in NeoGenomics, Inc. NASDAQ:NEO during the 2nd quarter, Holdings Channel reports. The institutional investor purchased 1,025 shares of the medical research companys stock, valued at approximately 31,000. A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ... 